| Code | 0999D | ||||||||||
| MA number | 44/0092/19-S | ||||||||||
| Product Form: | tbl flm 28x200 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 01.04.2019 |
| SPC: |
SPC_Sorafenib Teva 200 mg_07.2022.pdf
|
| PIL: |
PIL_Sorafenib Teva 200 mg_01.2024.pdf
|
| Safety feature | Yes |
| Data update: | 07.11.2023 |
